Market access and managed entry programmes
Wiley-Blackwell’s stable of medical controlled circulation (CC) titles can support a whole range of advertising and sponsored medical communication and education activities including managed entry programmes for new products, advisory panel research, reprints, supplements, meetings and online CPD.
Drawing on our publications, associations and key opinion leader network, we offer guidance on the increasingly complex healthcare environment to ensure the development of credible peer reviewed education that brings value to healthcare professionals and sponsor.
Our publications provide the ideal vehicle to target advertising, medical communication and education cost effectively.
Our editorial team and project managers can provide a full service from ideas generation to delivery, or are happy to work with a sponsor’s internal team or agency to deliver high quality medical communications.
Managed entry programmes
One of the key elements of a managed entry programme is that it aims to be beneficial to all: pharmaceutical manufacturers; the NHS, and patients. This is best achieved by collaborative working with key decision makers to help them prepare for the arrival of a product or licence variation. Key decision-makers need to know prior to launch about new drugs, new formulations and extended indications, as these can have an impact on the organisation of care and prescribing budgets. A fundamental need is to ensure peer reviewed reader friendly, communication reaches all potential prescribers and influencers. Through Future Prescriber and Prescriber associated managed entry initiatives we can ensure the right information is delivered at the right time to the right stakeholders.
For information please contact:
Head of Business Development
tel: 01243 770319